The Division of Cardiac Surgery, Department of Surgery, Western University, Lawson Health Research Institute, London Health Sciences Centre, London, Ont., Canada.
Can J Surg. 2013 Jun;56(3):180-6. doi: 10.1503/cjs.033111.
Research has demonstrated equivalent patient safety outcomes for various cardiac procedures when the primary surgeon was a supervised trainee. However, cardiac surgery cases have become more complex, and the Canadian cardiac surgery education model has undergone some changes. We sought to compare patient safety and efficiency of aortic valve replacement (AVR) between Canadian patients treated by senior cardiac trainees and those treated by certified cardiac surgeons.
We completed a single-centre, case-matched, prospectively collected and retrospectively analyzed study of AVR. Patients were matched between trainees and consultants for age, sex, New York Heart Association and Canadian Cardiovascular Society status, urgency of operation and diabetes status.
We analyzed 1102 procedures: 624 isolated AVRs and 478 AVRs with coronary artery bypass graft (CABG). For isolated AVR, there was no significant difference in 30-d mortality (p = 0.13) or in major adverse events (p = 0.38) between the groups. In the AVR+CABG group, there was no significant difference in 30-day mortality (p = 0.10) or in the rates of major adverse events (p = 0.37) between the groups. Secondary outcomes (hospital and intensive care unit lengths of stay, valve size and type) did not differ significantly between the groups for isolated AVR or AVR+CABG.
Despite a higher-risk patient population and changes in the cardiac surgery training model, it appears that outcomes are not negatively affected when a senior trainee acts as the primary surgeon in cases of AVR.
研究表明,当主要外科医生是受监督的受训者时,各种心脏手术的患者安全结果相当。然而,心脏手术的病例变得更加复杂,加拿大心脏手术教育模式也发生了一些变化。我们试图比较由高级心脏受训者和认证的心脏外科医生治疗的加拿大患者的主动脉瓣置换术(AVR)的患者安全性和效率。
我们完成了一项单中心、病例匹配、前瞻性收集和回顾性分析的 AVR 研究。受训者和顾问之间根据年龄、性别、纽约心脏协会和加拿大心血管学会状态、手术紧急情况和糖尿病状况对患者进行匹配。
我们分析了 1102 例手术:624 例孤立性 AVR 和 478 例 AVR 加冠状动脉旁路移植术(CABG)。对于孤立性 AVR,两组间 30 天死亡率(p = 0.13)或主要不良事件(p = 0.38)无显著差异。在 AVR+CABG 组中,两组间 30 天死亡率(p = 0.10)或主要不良事件发生率(p = 0.37)无显著差异。孤立性 AVR 或 AVR+CABG 组间次要结局(住院和重症监护病房的住院时间、瓣膜大小和类型)无显著差异。
尽管患者人群风险更高且心脏手术培训模式发生了变化,但当高级受训者担任 AVR 的主要外科医生时,结果似乎并未受到负面影响。